C12N 2740/11023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2740/11023 (Virus like particles [vlp]) appears on 9 US grants and 13 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 13
- Assignees
- 10
- Inventors
- 10
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 3 |
| 2021 | 1 | 2 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 2 | 3 |
| 2025 | 2 | 0 |
By publication year.
Recent patents
- VLP-based monovalent ebola vaccines and methods of making and using same30 Sep 2025US 12,427,190 B2Children's Hospital Medical Center
- VLP-based bivalent Ebola vaccines and methods of making and using same22 Apr 2025US 12,280,100 B2Children's Hospital Medical Center
- Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon30 Jul 2024US 12,049,639 B2The USA, as represented by the Secretary, Dept. of Health and Human Services
- VLP-based bivalent ebola vaccines and methods of making and using same6 Feb 2024US 11,890,337 B2Children's Hospital Medical Center
- Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon8 Aug 2023US 11,718,861 B2The USA, as represented by the Secretary, Dept. of Health and Human Services
- Self-Amplifying RNA-Based VLP Vaccines22 Aug 2024US 2024/0277836 A1Chimeron Bio Corporation
- Compositions of glycoprotein particles27 Jun 2024US 2024/0207196 A1Scribe Therapeutics Inc.
- Vlp-based bivalent ebola vaccines and methods of making and using same25 Apr 2024US 2024/0131141 A1Children's Hospital Medical Center
- Cancer immunotherapy by delivering class ii mhc antigens using a vlp-replicon17 Aug 2023US 2023/0257775 A1The USA as represented by the Secretary of Health and Human Services
- Vlp-based bivalent ebola vaccines and methods of making and using same16 Dec 2021US 2021/0386849 A1Children's Hospital Medical Center
Most cited
By later US patents
- Delivery of packaged RNA to mammalian cells6US 10,538,743 B2The USA, as represented by the Secretary, Dept. of Health and Human Services · 2020
- Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS5US 8,920,812 B2Takeda Vaccines, Inc. · 2014
- Delivery of packaged RNA to mammalian cells3US 9,506,041 B2The United States of America, as represented by the Secretary, Dept. of Health and Human Services · 2016
- VLP-based bivalent Ebola vaccines and methods of making and using same2US 11,129,886 B2Children's Hospital Medical Center · 2021
- Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon1US 11,718,861 B2The USA, as represented by the Secretary, Dept. of Health and Human Services · 2023